Subcutaneous Bioavailability
Subcutaneous Bioavailability is the fraction of an administered drug that reaches the systemic circulation following subcutaneous injection, distinguishing it from other routes of administration by its specific absorption kinetics and bioavailability profile.
81
Publications
3.3K
Citations
470
Authors
174
Institutions
Publications per year
2017–2026
25
81
1–5 of 81
470
4
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 470
174

Research Triangle Park Foundation
Durham, United States
5 h-index
7 publications
237 citations
Gilead Sciences (United States)
Foster City, United States
4 h-index
8 publications
461 citations
Wellcome Library
London, United Kingdom
4 h-index
10 publications
438 citations
Schmerzmedizin Berlin
Berlin, Germany
4 h-index
4 publications
153 citations

University of Bologna
Bologna, Italy
4 h-index
4 publications
153 citations
St. Joseph's Hospital
London, Canada
4 h-index
4 publications
153 citations

Johns Hopkins University
Baltimore, United States
4 h-index
11 publications
508 citations
Roche (Switzerland)
Basel, Switzerland
4 h-index
7 publications
1.1K citations
1–8 of 174
6 publications · 569 citations
6
h-index
4 publications · 93 citations
4
h-index
4 publications · 153 citations
4
h-index
3 publications · 195 citations
3
h-index
2 publications · 111 citations
2
h-index
1–5